Biocon's Kiran Mazumdar-Shaw rings Nasdaq bell for niece's Bicara Therapeutics' Billion-Dollar debut

Kiran Mazumdar-Shaw beams with pride as her niece, Claire Mazumdar, leads Bicara Therapeutics to a successful billion-dollar IPO at Nasdaq.

By  Storyboard18Sep 27, 2024 12:38 PM
Biocon's Kiran Mazumdar-Shaw rings Nasdaq bell for niece's Bicara Therapeutics' Billion-Dollar debut
Claire Mazumdar's Boston-based biopharmaceutical company, Bicara Therapeutics, made a billion-dollar debut, with both women celebrating the significant milestone by ringing the opening bell. (Left to Right: Claire Mazumdar, Kiran Mazumdar-Shaw)

Kiran Mazumdar-Shaw, founder and chairperson of Biocon, shared a moment of personal and professional pride on Wednesday, accompanying her niece Claire Mazumdar at the Nasdaq stock exchange in New York City. Claire Mazumdar's Boston-based biopharmaceutical company, Bicara Therapeutics, made a billion-dollar debut, with both women celebrating the significant milestone by ringing the opening bell.

Mazumdar-Shaw expressed her excitement on social media, writing, "Thrilled to be present at ringing the opening bell for Bicara Therapeutics' debut on Nasdaq exchange. So very proud of my amazing niece Claire Mazumdar... I am bursting with pride to see Indian innovation being valued in the world's most respected stock exchange." Claire Mazumdar, the founding CEO of Bicara, led the company to this momentous occasion, marking a major achievement in her entrepreneurial journey.

Bicara Therapeutics, a clinical-stage biopharmaceutical company, is focused on developing bifunctional therapies aimed at treating patients with solid tumors. The company's lead drug, ficerafusp alfa, is currently undergoing an early-stage study in the US in combination with Merck's cancer therapy, Keytruda, to treat head and neck cancers.

The successful IPO marks a new chapter for the company, which plans to use part of the proceeds to fund a mid-to-late stage clinical trial for ficerafusp alfa, expected to commence by late 2024 or early 2025.

First Published on Sep 27, 2024 12:38 PM

More from Storyboard18

Brand Makers

Pidilite Industries' CBO - Construction Chemicals Salil Dalal steps down

Pidilite Industries' CBO - Construction Chemicals Salil Dalal steps down

Brand Makers

Apple's new COO Sabih Khan joins club of Indian-origin global tech leaders

Apple's new COO Sabih Khan joins club of Indian-origin global tech leaders

Brand Makers

Analysts bet on continuity and consumer focus with Priya Nair at HUL

Analysts bet on continuity and consumer focus with Priya Nair at HUL

Brand Makers

Titan names new CEOs for Jewellery and Watches Divisions as leadership transition continues

Titan names new CEOs for Jewellery and Watches Divisions as leadership transition continues

Brand Makers

'She taught me purpose': How Priya Nair’s mother shaped HUL’s first woman CEO

'She taught me purpose': How Priya Nair’s mother shaped HUL’s first woman CEO

Brand Makers

Rohit Jawa to step down as CEO of Hindustan Unilever, Priya Nair named as successor

Rohit Jawa to step down as CEO of Hindustan Unilever, Priya Nair named as successor

Brand Makers

Who is Priya Nair - the first-ever female CEO and MD of HUL?

Who is Priya Nair - the first-ever female CEO and MD of HUL?

Brand Makers

HUL announces Priya Nair as CEO and MD

HUL announces Priya Nair as CEO and MD